Edgewell Personal Care Company (EPC) SEC Filings & Earnings Calls
EquiReason read 13 Edgewell Personal Care Company SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Edgewell Personal Care announced LaTanya Langley will serve as Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026; no compensation change..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 20268-K · 2.02Net sales $570M (+2% y/y); Organic net sales growth 1.1; Adjusted EPS $0.72 (+0% y/y); Guidance: Full year outlook narrowed; midpoints for adjusted EPS and adjusted EBITDA unchanged.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2026 | $570M | +2% y/y |
| Organic net sales growth · Q3-2026 | 1.1% | |
| Adjusted EPS · Q3-2026 | $0.72 | 0% y/y |
| Adjusted EBITDA · Q3-2026 | $79M | -3% y/y |
| Adjusted gross margin · Q3-2026 | 44.5% | |
| GAAP diluted EPS · Q3-2026 | $0.26 | -44% y/y |
| Cash on hand · Q3-2026 | $397M |
Guidance
Full year outlook narrowed; midpoints for adjusted EPS and adjusted EBITDA unchanged.
Narrowed full-year outlook with midpoints unchanged; management confident in back-half weighted year.
Risks flagged
Core inflation and net tariffs impacting gross margin by 160bps, partially offset by productivity.
“Productivity savings of approximately 200-basis points and 40-basis points of favorable currency movements were more than offset by 160-basis points of core inflation and net tariffs and 110-basis points of unfavorable mix and promotional levels” · word for word
International sales decline due to Middle East conflict and supply chain disruption from Wet Shave consolidation.
“International organic sales declined 1.4%, primarily reflecting temporary disruption associated with the conflict in the Middle East and short-term supply chain impacts related to the Company's Wet Shave manufacturing consolidation” · word for word
Restructuring costs of $24.5M in the quarter, indicating ongoing cost efficiency programs.
“The Company recorded pre-tax restructuring and related costs in support of cost efficiency and effectiveness programs of $24.5 million in the quarter” · word for word
5 Aug 202610-QEdgewell reported Q3 FY2026 results with net sales up 1.7% YoY, but GAAP net income down 43% due to restructuring costs and margin pressure.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2026 | $570M | +2% y/y |
| Organic Net Sales Growth · Q3-2026 | 1.1% | |
| GAAP Gross Margin · Q3-2026 | 42.5% | |
| Adjusted Gross Margin · Q3-2026 | 44.5% | |
| Net Earnings from Continuing Operations · Q3-2026 | $12M | -43% y/y |
| Adjusted Net Earnings from Continuing Operations · Q3-2026 | $34M | -0% y/y |
| Diluted EPS from Continuing Operations · Q3-2026 | $0.26 | -43% y/y |
| Adjusted Diluted EPS from Continuing Operations · Q3-2026 | $0.72 | 0% y/y |
| Wet Shave Segment Net Sales · Wet Shave · Q3-2026 | $313M | -1% y/y |
| Wet Shave Segment Profit · Wet Shave · Q3-2026 | $35M | -21% y/y |
Risks flagged
Tariff Input Cost Pressure
“Productivity savings of approximately 200-basis points and 40-basis points of favorable currency movements were more than offset by 160-basis points of core inflation and net tariffs and 110-basis points of unfavorable mix and promotional levels (net of pricing).” · word for word
Supply Chain Disruption
“International organic sales declined 1.4%, primarily reflecting temporary disruption associated with the conflict in the Middle East and short-term supply chain impacts related to the Company's Wet Shave manufacturing consolidation” · word for word
Restructuring Execution Risk
“We incurred $12.7 and $14.9 during the third quarter of fiscal 2026 and 2025, respectively, and $44.8 and $30.9 during the first nine months of fiscal 2026 and 2025, respectively.” · word for word
26 May 20268-K · 5.02, 7.01Chief Supply Chain Officer Paul Hibbert departing June 1, 2026; Anthony Freve appointed as successor same date. Routine executive transition.open
Risks flagged
Minimal risk; transition appears orderly with successor named.
“Successor appointed effective same date as departure.”
6 May 20268-K · 2.02Net Sales $520M (+1% y/y); Organic Net Sales Growth -2.4; Adjusted EPS $0.60 (-13% y/y); Guidance: Full-year outlook reaffirmed for organic net sales, adjusted EPS, EBITDA, and adjusted free cash flowearningsopen
Figures in the filing · each found in the filing text
| Net Sales · total · Q2-2026 | $520M | +1% y/y |
| Organic Net Sales Growth · total · Q2-2026 | -2.4% | |
| Adjusted EPS · total · Q2-2026 | $0.60 | -13% y/y |
| GAAP Diluted EPS · total · Q2-2026 | $0.09 | -79% y/y |
| Gross Profit · total · Q2-2026 | $217M | -8% y/y |
| Adjusted Gross Margin · total · Q2-2026 | 43.4% | |
| Operating Income · total · Q2-2026 | $18M | -62% y/y |
| Adjusted Operating Income · total · Q2-2026 | $49M | -25% y/y |
| Cash on Hand · total · Q2-2026 | $300M | |
| Share Repurchases · total · Q2-2026 | $16M |
Guidance
Full-year outlook reaffirmed for organic net sales, adjusted EPS, EBITDA, and adjusted free cash flow
Full-year guidance reaffirmed despite Q2 margin pressure, with management expressing confidence in returning to organic growth and margin expansion.
Risks flagged
Tariff and inflation pressures are significant, causing gross margin contraction of 310 bps.
“Productivity savings of approximately 220-basis points were more than offset by 420-basis points of core inflation and tariffs.” · word for word
North America organic sales decline of 4.8% indicates demand weakness in key market.
“Organic sales declined in North America by 4.8%, driven primarily by lower volumes in Wet Shave and Sun Care.” · word for word
6 May 202610-QNet Sales $520M (+1% y/y); Organic Net Sales Growth -2.4; Gross Margin 41.8open
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $520M | +1% y/y |
| Organic Net Sales Growth · Q2-2026 | -2.4% | |
| Gross Margin · Q2-2026 | 41.8% | |
| Adjusted Gross Margin · Q2-2026 | 43.4% | |
| Net Income from Continuing Operations · Q2-2026 | $4M | -81% y/y |
| Adjusted Net Income from Continuing Operations · Q2-2026 | $28M | -16% y/y |
| Diluted EPS from Continuing Operations · Q2-2026 | $0.09 | -79% y/y |
| Adjusted Diluted EPS from Continuing Operations · Q2-2026 | $0.60 | -13% y/y |
| Wet Shave Segment Net Sales · Wet Shave · Q2-2026 | $294M | +3% y/y |
| Wet Shave Segment Profit · Wet Shave · Q2-2026 | $34M | -28% y/y |
Risks flagged
Tariff and Inflation Margin Pressure
“Productivity savings of approximately 220-basis points were more than offset by 420-basis points of core inflation and tariffs” · word for word
North America Demand Weakness
“Organic sales declined in North America by 4.8%, driven primarily by lower volumes in Wet Shave and Sun Care” · word for word
Restructuring Execution Risk
“We expect to incur pre-tax charges of approximately $90 in fiscal 2026.” · word for word
9 Feb 20268-K · 2.02, 5.02, 5.07, 7.01Released earnings results and quarterly financials; reported the departure of a director or principal officer (CEO/CFO change)earningsopen
Risks flagged
Potential dilution from increased authorized shares under stock incentive plan
“Increases the number of authorized shares by 2,100,000 shares” · word for word
9 Feb 202610-QEdgewell reported Q1 fiscal 2026 results with organic sales down 0.5%, GAAP gross margin down 350 bps, and adjusted net loss widening, while completing the Feminine Care divestiture.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $423M | +2% y/y |
| Organic Net Sales Growth · Q1-2026 | -0.5% | |
| Gross Margin (GAAP) · Q1-2026 | 38.1% | |
| Net Loss from Continuing Operations (GAAP) · Q1-2026 | $-29M | |
| Adjusted Diluted EPS from Continuing Operations · Q1-2026 | $-0.16 | |
| Wet Shave Segment Net Sales · Wet Shave · Q1-2026 | $291M | -1% y/y |
| Operating Cash Flow · Q1-2026 | $-126M | |
| Capital Expenditures · Q1-2026 | $12M | -31% y/y |
Risks flagged
Input cost and tariff pressure on margins
“Productivity savings of approximately 240-basis points and favorable currency movements were more than offset by 450-basis points of core inflation, tariffs, volume absorption and 75-basis points of unfavorable mix and other.” · word for word
Wet Shave segment demand weakness
“North America declined 8.3% as a result of decreased volumes and increased promotional levels.” · word for word
Restructuring execution risk
“We expect to incur pre-tax charges of approximately $65 in fiscal 2026. We incurred $18.1 and $4.1 during the first three months of fiscal 2026 and 2025, respectively.” · word for word
6 Feb 20268-K · 2.01, 7.01Cash proceeds from sale $340Macquisitionopen
Figures in the filing · each found in the filing text
| Cash proceeds from sale · Feminine Care · Q1-2026 | $340M |
Risks flagged
Loss of Feminine Care revenue stream and potential transition service risks.
“sale of its Feminine Care segment ... transition services agreement”
22 Dec 2025DEF 14AProxy statement disclosing executive compensation, incentive plan metrics, pay-for-performance alignment, and governance practices for fiscal 2025.open
Figures in the filing · each found in the filing text
| Adjusted EBITDA H12025 · H1-2025 | $145M | |
| Adjusted Net Sales H12025 · H1-2025 | $1.08B | |
| Adjusted EBITDA H22025 · H2-2025 | $157M | |
| Adjusted Net Sales H22025 · H2-2025 | $1.16B | |
| International Organic Growth · International · FY2025 | 3.5% | |
| Gross Margin Savings · FY2025 | 270.0% | |
| Annual Incentive Payout · FY2025 | 66.0% | |
| PRSE Payout (FY2022 grant) · FY2025 | 70.6% | |
| CEO Total Compensation (SCT) · FY2025 | $10M | |
| CEO Compensation Actually Paid · FY2025 | $-2M |
Risks flagged
Tariff and FX Volatility
“We navigated a complex environment marked by external pressures — including tariffs, exchange volatility, and geopolitical uncertainty — that impacted our financial performance and stressed our global supply chain.” · word for word
Sun Care Seasonality Risk
“weaker-than-expected Sun Care seasons in North America and parts of Latin America” · word for word
Feminine Care Recovery Risk
“a slower-than-expected recovery in our Feminine Care business” · word for word
Stock Price Volatility Impact on Director/Executive Ownership Compliance
“as of September 30, 2025, Carla Hendra and Swan Sit were no longer in compliance solely due to fluctuations in our stock price.” · word for word
Key Person Departure Risk
“Daniel J. Sullivan, Former Chief Financial Officer and Chief Operating Officer departed October 2025” · word for word
18 Nov 202510-KNet Sales $2.22B (-1% y/y); Gross Margin 41.6; Adjusted Gross Margin 42; Guidance: Capex guided $70-80M for FY2026; no revenue or margin guidance provided.open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $2.22B | -1% y/y |
| Gross Margin · FY2025 | 41.6% | |
| Adjusted Gross Margin · FY2025 | 42.0% | |
| Net Earnings · FY2025 | $25M | -74% y/y |
| Adjusted Net Earnings · FY2025 | $120M | -21% y/y |
| Diluted EPS · FY2025 | $0.53 | -73% y/y |
| Adjusted Diluted EPS · FY2025 | $2.52 | -17% y/y |
| Operating Cash Flow · FY2025 | $118M | -49% y/y |
| Capital Expenditures · FY2025 | $77M | +36% y/y |
| Total Debt · FY2025 | $1.42B | +9% y/y |
Guidance
Capex guided $70-80M for FY2026; no revenue or margin guidance provided.
Capex guidance of $70-80M for FY2026, up from $77M in FY2025, focused on maintenance and productivity. No revenue or margin guidance provided.
Risks flagged
Debt Covenant Compliance Risk
“Our failure to make scheduled interest payments or to repay or refinance the indebtedness at maturity or obtain additional financing as needed could have a material adverse effect on our business.” · word for word
Goodwill Impairment Risk
“Declines in our profitability and estimated cash flows related to specific intangible assets... may result in an impairment charge.” · word for word
Divestiture Execution Risk
“there can be no assurances that sale of the Feminine Care business will close on the anticipated timelines or at all” · word for word
13 Nov 20258-K · 1.01, 7.01Sale Price $340Mopen
Figures in the filing · each found in the filing text
| Sale Price · Feminine Care | $340M |
Risks flagged
Transaction subject to regulatory approvals and closing conditions.
“Subject to customary closing conditions, including regulatory approvals.”
Stranded overhead costs may partially offset benefits.
“Expects to incur certain stranded overhead costs.” · word for word
13 Nov 20258-K · 2.02Net Sales $537M (+4% y/y); Organic Net Sales Growth 2.5; Adjusted EPS $0.68; Guidance: Return to organic sales growth in FY2026earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q4-2025 | $537M | +4% y/y |
| Organic Net Sales Growth · Q4-2025 | 2.5% | |
| Adjusted EPS · Q4-2025 | $0.68 | |
| Full Year Net Sales · FY2025 | $2.22B | -1% y/y |
| Full Year Adjusted EPS · FY2025 | $2.52 | |
| Cash and Cash Equivalents · Q4-2025 | $226M | |
| Net Debt Leverage Ratio · Q4-2025 | $3.90 | |
| Dividend per Share · Q4-2025 | $0.15 | |
| Share Repurchase Authorization · FY2026 | $100M |
Guidance
Return to organic sales growth in FY2026
Management expects organic sales growth in FY2026, with margin recovery.
Risks flagged
Gross margin pressure from tariffs and unfavorable mix.
“Adjusted gross margin decreased 330-basis points, including 100 bps from tariffs.”
Currency headwinds impacting earnings.
“Full year adjusted EPS includes $0.48 unfavorable impact from currency.”
Edgewell Personal Care Company — questions
- What did Edgewell Personal Care Company file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Edgewell Personal Care announced LaTanya Langley will serve as Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026; no compensation change.
Every figure on this page comes from Edgewell Personal Care Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.